Episodic retreatment versus scheduled maintenance therapy of crohn's disease with infliximab: not so far apart.
Sartor
R Balfour
RB
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003424:Crohn Disease / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D000069285:Infliximab; D019233:Retreatment
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab